Zacks
0
All posts from Zacks
Zacks in Our Research. Your Success.,

Concordia International (CXRX) Catches Eye: Stock Jumps 9.9%

Concordia International Corp. CXRX was a big mover last session, as the company saw its shares rise almost 10% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $1.11 to $1.41 in the past one-month time frame.

None of the estimates for this stock were revised over the past 30 days. The Zacks Consensus Estimate also remained unchanged over the same time frame. Friday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Concordia International currently carries a Zacks Rank #5 (Strong Sell), while its Earnings ESP is 0.00%.

A better-ranked stock worth considering from the Medical-Drugs space is MEI Pharma, Inc. MEIP, sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is CXRX going up? Or down? Predict to see what others think: Up or Down

5 Trades Could Profit ""Big-League"" from Trump Policies   

If the stocks above spark your interest, wait until you look into companies primed to make substantial gains from Washington's changing course.

Today Zacks reveals 5 tickers that could benefit from new trends like streamlined drug approvals, tariffs, lower taxes, higher interest rates, and spending surges in defense and infrastructure. See these buy recommendations now >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
MEI Pharma, Inc. (MEIP): Free Stock Analysis Report
 
Concordia International Corp. (CXRX): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research